The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Abstract
The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is an inverse relationship between serum HDL levels and the risk of coronary heart disease49,50.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [49]
In the citing paper
“For many decades, a low level of HDL-C has been viewed as a robust and independent CVD risk factor1-4.”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [1]
Citations
Cites
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456
Research works printed but not linked: 13
- Miller, 1973, J. Lab. clin. Med., 82, 876
- Goodman, 1973, J. Lipid Res., 52, 2646
- Insull, 1968, J. Lab. clin. Med., 72, 885
- Schreibman, 1973, Clin. Res., 21, 638
- P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
- Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
- Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
- N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
- Kannel, 1962, Geriatrics, 17, 675
- Murphy, 1962, J. Lab. clin. Med., 60, 86
- Kudchodkar, 1972, Clin. Res., 20, 944
- Jones, 1970, J. Lab. clin. Med., 75, 953
- Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123
Cited by
Sorted by citations
Items 701–800 of 1,001
PADGEM/GMP‐140 expression on platelet membranes from homozygous beta thalassaemic patients
Principe, D. D., Menichelli, A., Giulio, S. D., Matteis, W. D., Cianciulli, P., & Papa, G. F. S. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03033.x · Cited by 54
Kark, J. D., Sinnreich, R., Leitersdorf, E., Friedlander, Y., Shpitzen, S., & Luc, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00408-6 · Cited by 54
Predictability of coronary heart disease
Gordon, T., Kannel, W. B., & Halperin, M. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90103-6 · Cited by 54
Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2.
Kambouris, A. M., Roach, P. D., Calvert, G. D., & Nestel, P. J. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.582 · Cited by 54
Serum Lipid and Lipoprotein Concentrations in Chronic Uremia
Norbeck, H., Orö, L., & Carlson, L. A. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08270.x · Cited by 54
van Berkel, T. J. C., Kruijt, J. K., & Kempen, H. J. M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39009-9 · Cited by 54
Hulley, S. B., Ashman, P., Kuller, L. H., Lasser, N. L., & Sherwin, R. W. (1979) · Lipids · doi:10.1007/bf02533580 · Cited by 54
LeFevre, M. L., Sloop, C. H., & Roheim, P. S. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38454-6 · Cited by 54
Dory, L., Boquet, L. M., Hamilton, R. L., Sloop, C. H., & Roheim, P. S. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34338-8 · Cited by 54
Comparison of Lovastatin and Gemfibrozil in Normolipidemic Patients With Hypoalphalipoproteinemia
Vega, G. L. (1989) · JAMA · doi:10.1001/jama.1989.03430220071033 · Cited by 54
LCAT- targeted therapies: Progress, failures and future
Yang, K., Wang, J., Xiang, H., Ding, P., Wu, T., & Ji, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112677 · Cited by 55
The Role of High-Density Lipoprotein Cholesterol in 2022
Sirtori, C. R., Corsini, A., & Ruscica, M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01012-y · Cited by 55
Dyslipidemia in the Elderly: Should it Be Treated?
Shanmugasundaram, M., Rough, S. J., & Alpert, J. S. (2010) · Clinical Cardiology · doi:10.1002/clc.20702 · Cited by 55
Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments
Digby, J. E., Ruparelia, N., & Choudhury, R. P. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.236315 · Cited by 53
Lindqvist, H. M., Langkilde, A. M., Undeland, I., & Sandberg, A. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508003073 · Cited by 53
High-density lipoprotein, low-density lipoprotein, and coronary heart disease.
Miller, G. J. (1978) · Thorax · doi:10.1136/thx.33.2.137 · Cited by 53
Self-citationHigh-density Lipoprotein and Inflammation and Its Significance to Atherosclerosis
Hu, J., Xi, D., Zhao, J., Luo, T., Liu, J., Lu, H., Li, M., Xiong, H., & Guo, Z. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.06.014 · Cited by 53
Zoubi, S. A., Mayhew, T. M., & Sparrow, R. A. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00193174 · Cited by 53
King, J. M., Crouse, J. R., Terry, J. G., Morgan, T. M., Spray, B. J., & Miller, N. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90298-4 · Cited by 53
Self-citationFalchi, M., Forabosco, P., Mocci, E., Borlino, C. C., Picciau, A., Virdis, E., Persico, I., Parracciani, D., Angius, A., & Pirastu, M. (2004) · The American Journal of Human Genetics · doi:10.1086/426155 · Cited by 53
HIGH-DENSITY LIPOPROTEIN AND PHYSICAL ACTIVITY
Miller, N. E., Rao, S. R., Lewis, B., Bjørsvik, G., Myhre, K., & Mjøs, O. D. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90107-7 · Cited by 53
Self-citationNative low density lipoprotein. Endothelial cell recruitment of mononuclear cells.
Pritchard, K. A., Tota, R. R., Lin, J. H.-C., Danishefsky, K. J., Kurilla, B. A., Holland, J. A., & Stemerman, M. B. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1175 · Cited by 53
Mechanistic studies of high-density lipoproteins
Kashyap, M. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00813-3 · Cited by 53
Lovastatin in the Treatment of Multifactorial Hyperlipidemia Associated With Proteinuria
Golper, T. A., Illingworth, D. R., Morris, C. D., & Bennett, W. M. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80038-1 · Cited by 53
Serum and urinary high density lipoproteins in glomerular disease with proteinuria
Short, C. D., Durrington, P. N., Mallick, N. P., Hunt, L. P., Tetlow, L. J., & Ishola, M. (1986) · Kidney International · doi:10.1038/ki.1986.131 · Cited by 53
EVOLUTION OF LIPOPROTEIN PATTERNS IN NEWBORNS
Biervliet, J. P. V., VERCAEMST, R., KEERSGIETER, W. D., Vinaimont, N., Caster, H., & Rosseneu, M. (1980) · Acta Paediatrica · doi:10.1111/j.1651-2227.1980.tb07327.x · Cited by 53
Daerr, W. H., & Greten, H. (1982) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(82)90142-4 · Cited by 53
Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter
Rufibach, L. E., Duncan, S. A., Battle, M., & Deeb, S. S. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600082-jlr200 · Cited by 52
Brill, A. G., Yesilaltay, A., Meyer, S. F. D., Kisucka, J., Fuchs, T. A., Kocher, O. N., Krieger, M., & Wagner, D. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252130 · Cited by 52
Human genetics of HDL: Insight into particle metabolism and function
Brunham, L. R., & Hayden, M. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.001 · Cited by 54
High-density lipoproteins (HDL): Novel function and therapeutic applications
Darabi, M., & Kontush, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159058 · Cited by 52
Mohrschladt, M. F., Beer, F. V. D. S.-D., Hofman, M., van der Krabben, M., Westendorp, R. G., & Smelt, A. H. M. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201426 · Cited by 52
Seppänen‐Laakso, T., Laakso, I., Vanhanen, H. T., Kiviranta, K., Lehtimäki, T. J., & Hiltunen, R. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00031-7 · Cited by 52
Effects of Garlic Products on Lipid Metabolism in Cholesterol-Fed Rats
Chi, M. S. (1982) · Experimental Biology and Medicine · doi:10.3181/00379727-171-41494 · Cited by 52
Dieplinger, H., Zechner, R., & Kostner, G. M. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34369-8 · Cited by 52
Zannis, V. I., & Breslow, J. L. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf00223534 · Cited by 53
Effect of smoking on serum levels of HDL apoproteins
Berg, K., Børresen‐Dale, A., & Dahlén, G. H. (1979) · Atherosclerosis · doi:10.1016/s0021-9150(79)80011-8 · Cited by 52
Zhu, L.-X., Luo, X., & Jin, Z. (2008) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2008.70638 · Cited by 51
Measurement-specific quality-of-life satisfaction during the menopause in an Arabian Gulf country
Bener, A., Rizk, D. E. E., Shaheen, H., Micallef, R., Osman, N., & Dunn, E. V. (2000) · Climacteric · doi:10.3109/13697130009167598 · Cited by 51
Li, Z., Yang, R., Xu, G., & Xia, T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038646 · Cited by 51
Lack of Protection against Oxidative Modification of LDL by Avian HDL
Mackness, B., Durrington, P. N., & Mackness, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8803 · Cited by 51
Peacock, R. E., Hamsten, A., Johansson, J., Nilsson‐Ehle, P., & Humphries, S. E. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04159.x · Cited by 53
Apolipoprotein A-I Zavalla (Leu 159 →Pro)
Miller, M. J., Aiello, D. P., Pritchard, H., Friel, G., & Zeller, K. I. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1242 · Cited by 51
Diabetes and Glucose Intolerance as Risk Factors for Stroke
Tuomilehto, J., & Rastenytė, D. (1999) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748739900600409 · Cited by 51
McKeigue, P., Laws, A., Chen, Y. I., Marmot, M. G., & Reaven, G. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1187 · Cited by 51
Serum cholinesterase: Function in lipoprotein metabolism
Kutty, K. M., Redheendran, R., & Murphy, D. (1977) · Cellular and Molecular Life Sciences · doi:10.1007/bf01922187 · Cited by 51
Woollett, L. A., & Spady, D. K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119334 · Cited by 51
The effects of a mixed fish diet on platelet function, fatty acids and serum lipids
Bradlow, B. A., Chetty, N., Westhuyzen, J., Mendelsohn, D., & Gibson, J. E. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90211-6 · Cited by 51
Lupien, P.-J., Moorjani, S., Lou, M., Brun, D., & Gagné, C. (1980) · Pediatric Research · doi:10.1203/00006450-198002000-00009 · Cited by 51
Godsland, I. F., & Crook, D. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)05015-5 · Cited by 51
The measurement of apolipoprotein A-I in human plasma by electroimmunoassay.
Miller, J. P., Mao, S. J. T., Patsch, J. R., & Gotto, A. M. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34804-5 · Cited by 51
High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management
Choi, H. Y., Hafiane, A., Schwertani, A. G., & Genest, J. J. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.09.012 · Cited by 51
High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases
Suda, K., Murakami, T., Gotoh, N., Fukuda, R., Hashida, Y., Hashida, M., Tsujikawa, A., & Yoshimura, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.036 · Cited by 51
Tanwar, B., Modgil, R., & Goyal, A. (2018) · Food & Function · doi:10.1039/c8fo00044a · Cited by 50
Burstein, M., Fine, A., Atger, V., Wirbel, E., & Girard-Globa, A. (1989) · Biochimie · doi:10.1016/0300-9084(89)90090-4 · Cited by 50
Klos, K. L. E., Sing, C. F., Boerwinkle, E., Hamon, S., Rea, T. J., Clark, A. G., Fornage, M., & Hixson, J. E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000231523.19199.45 · Cited by 50
Cyclic AMP-Specific Phosphodiesterase 4 Inhibitors Promote ABCA1 Expression and Cholesterol Efflux
Lin, G., & Bornfeldt, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6259 · Cited by 50
James, R. W., Proudfoot, A. E. J., & Pometta, D. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90343-3 · Cited by 50
Atherosclerosis: Current concepts on pathogenesis and interventional therapies
Yatsu, F. M., & Fisher, M. (1989) · Annals of Neurology · doi:10.1002/ana.410260102 · Cited by 50
Effect of low-fat diets on plasma high-density lipoprotein concentrations
Katan, M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.573s · Cited by 50
Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.
Miller, N. E. (1979) · Journal of Clinical Pathology · doi:10.1136/jcp.32.7.639 · Cited by 50
Self-citationRegulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages
Dory, L. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42030-9 · Cited by 50
Rabbits as a Model for the Study of Hyperlipoproteinemia and Atherosclerosis
SHORE, B., & Shore, V. G. (1976) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4618-7_7 · Cited by 50
Plasma hormones and lipids in men at different risk for coronary heart disease
Hill, P., Wynder, E. L., Garbaczewski, L., Garnes, H. A., Walker, A. R., & Helman, P. (1980) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.5.1010 · Cited by 50
Grow, T. E., & Fried, M. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34357-0 · Cited by 50
Inhibition of cholesterol synthesis by ketoconazole
Kraemer, F. B., & Pont, A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90816-8 · Cited by 50
Hu, X., Li, X., Xiao, C., Kong, L., Zhu, Q., & Song, Z. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.681858 · Cited by 49
Maïga, S. F., Kalopissis, A. D., & Chabert, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.027 · Cited by 53
Kimura, H., Miyazaki, R., Imura, T., Masunaga, S., Suzuki, S., Gejyo, F., & Yoshida, H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00285.x · Cited by 49
Lipids, Lipoproteins, and Cardiovascular Disease: Clinical Pharmacology Now and in the Future
Chait, A., & Eckel, R. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3940 · Cited by 48
Serum cholesterol of adults supplemented with brewer's yeast or chromium chloride
Wang, M. M., Fox, E. A., Stoecker, B. J., Menendez, C. E., & Chan, S. B. (1989) · Nutrition Research · doi:10.1016/s0271-5317(89)80059-4 · Cited by 49
An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.
Francis, A. A., & Pierce, G. N. (2011) · Europe PMC (PubMed Central) · Cited by 50
Role of behavior theory in behavioral medicine.
Epstein, L. H. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.60.4.493 · Cited by 49
Treatment of the Hyperlipidemia of the Nephrotic Syndrome: A Controlled Trial
Valeri, A. M., Gelfand, J. L., Blum, C. B., & Appel, G. B. (1986) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(86)80164-0 · Cited by 49
Hirano, K., Matsuzawa, Y., Sakai, N., Hiraoka, H., Nozaki, S., Funahashi, T., Yamashita, S., Kubo, M., & Tarui, S. (1992) · Metabolism · doi:10.1016/0026-0495(92)90101-f · Cited by 49
Conclusions from the VA-HIT study
Bloomfield, H. E., & Robins, S. J. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01010-9 · Cited by 49
Nicotinic acid and the prevention of coronary artery disease
Digby, J. E., Lee, J., & Choudhury, R. P. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832d3b9d · Cited by 48
Luthi, A. J., Lyssenko, N. N., Quach, D., McMahon, K. M., Millar, J. S., Vickers, K. C., Rader, D. J., Phillips, M. C., Mirkin, C. A., & Thaxton, C. S. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m054635 · Cited by 49
Advances in high-density lipoprotein physiology: surprises, overturns, and promises
Constantinou, C., Karavia, E. A., Xepapadaki, E., Πετροπούλου, Π.-Ι., Παπακώστα, Ε., Karavyraki, M., Zvintzou, E., Theodoropoulos, V., Filou, S., Hatziri, A., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00429.2015 · Cited by 48
Dong, J. Q., Zhang, H., Jiang, X., Wang, S. Z., Du, Z., Wang, Z. P., Leng, L., Cao, Z. P., Li, Y. M., Luan, P., et al. (2015) · Journal of Animal Science · doi:10.2527/jas.2015-8871 · Cited by 49
Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice
Zhao, Y., Dai, X.-Y., Zhou, Z., Zhao, G., Wang, X., & Xu, M. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.88 · Cited by 49
Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity
Zvintzou, E., Lhomme, M., Chasapi, S., Filou, S., Theodoropoulos, V., Xapapadaki, E., Kontush, A., Spyroulias, G. A., Tellis, C. C., Tselepis, A. D., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m077925 · Cited by 48
Tisi, G. M., Conrique, A., Barrett-Connor, E. L., & Grundy, S. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90113-x · Cited by 48
Albrecht, C., Simon-Vermot, I., Elliott, J. I., Higgins, C. F., Johnston, D. G., & Valabhji, J. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.009 · Cited by 48
Charles‐Schoeman, C., Banquerigo, M. L., Hama, S. Y., Navab, M., Park, G. S., Lenten, B. J. V., Wagner, A. C., Fogelman, A. M., & Brahn, E. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.016 · Cited by 48
Apolipoprotein AI and alcoholic liver disease
Poynard, T., Abella, A., Pignon, J., Naveau, S., Leluc, R., & Chaput, J. (1986) · Hepatology · doi:10.1002/hep.1840060628 · Cited by 48
Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins
Brewer, H. B. (1981) · Journal of Molecular Medicine · doi:10.1007/bf01747745 · Cited by 48
Daerr, O. H., Gianturco, S. H., Patsch, J. R., Smith, L. C., & Gotto, A. M. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90077-6 · Cited by 48
Lipids, Diabetes, and Vascular Disease: The Time to Act
Betteridge, D. J. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01149.x · Cited by 48
POSSIBLE CONGENITAL DEFECT IN PLATELET THROMBOXANE SYNTHETASE
Weiss, H., & Lages, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92213-9 · Cited by 48
Hypolipidaemic Activity in Rats of Bergenin, the Major Constituent of Flueggea microcarpa
Jahromi, M. A. F., Chansouria, J. P. N., & Ray, A. B. (1992) · Phytotherapy Research · doi:10.1002/ptr.2650060403 · Cited by 47
Atherogenic lipoprotein changes in diabetic nephropathy
Shoji, T. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00673-0 · Cited by 47
Yesilaltay, A., Daniels, K. A., Pal, R., Krieger, M., & Kocher, O. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008103 · Cited by 47
Atherosclerosis and physical activity
Schneider, S. H., Vitug, A. C., & Ruderman, N. B. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610010410 · Cited by 47
Scavenger receptor class B Type I (SR-BI) assembles into detergent-sensitive dimers and tetramers
Sahoo, D., Darlington, Y. F., Pop, D., Williams, D. L., & Connelly, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.003 · Cited by 47
High density lipoprotein cholesterol and coronary artery occlusion
Barboriak, J. J., Anderson, A. J., Rimm, A. A., & King, J. F. (1979) · Metabolism · doi:10.1016/0026-0495(79)90178-1 · Cited by 47
Immunochemical determination of human apolipoprotein B by laser nephelometry
Fiévet, C., Dedonder, E., Fruchart, J., Dewailly, P., & Sézille, G. (1979) · Clinica Chimica Acta · doi:10.1016/0009-8981(79)90384-x · Cited by 47
Panduro, A., Lin-Lee, Y.-C., Chan, L., & Shafritz, D. A. (1990) · Biochemistry · doi:10.1021/bi00488a033 · Cited by 47
Hornstra, G. (1989) · Elsevier eBooks · doi:10.1016/b978-0-12-718051-9.50009-3 · Cited by 47
Krauss, R. M., Roy, S., Mishell, D. R., Casagrande, J. T., & Pike, M. C. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90315-0 · Cited by 47
Metadata
- Authors
- Miller, G. J., & Miller, N. E.
- Affiliations
- University Hospital Llandough (GB)
- Edinburgh Royal Infirmary (GB)
- ORCID
- Miller, G.J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1975-01
- Volume
- 305
- Issue
- 7897
- Pages
- 16-19
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1994967652
- Cited by
- 2,621
- References
- 59
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
- FWCI
- 157.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
- MeSH terms
- Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review